# Analysis of CRBSI Rates in Patients With a NexSite™ HD (Hemodialysis) Catheter

Study · id `cardio:ct-nct02453646` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02453646](<https://clinicaltrials.gov/study/NCT02453646>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02453646

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

## Technical summary

Registry record NCT02453646. Allocation not applicable; no masking; primary purpose other. Start 2015-04 (actual); primary completion 2017-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT02453646, source copy `cardio:ctgov-nct02453646-2018-10-01`, retrieved 2026-10-26)
- Started: 2015-04 (actual) (ClinicalTrials.gov record NCT02453646, source copy `cardio:ctgov-nct02453646-2018-10-01`, retrieved 2026-10-26)
- Primary completion: 2017-09 (actual) (ClinicalTrials.gov record NCT02453646, source copy `cardio:ctgov-nct02453646-2018-10-01`, retrieved 2026-10-26)
- Completion: 2018-07 (actual) (ClinicalTrials.gov record NCT02453646, source copy `cardio:ctgov-nct02453646-2018-10-01`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02453646, source copy `cardio:ctgov-nct02453646-2018-10-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02453646-2018-10-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Analysis of CRBSI Rates in Patients With a NexSite™ HD (Hemodialysis) Catheter
- Condition: End Stage Renal Disease
- Intervention (Device): NexSite HD Patients
- Lead sponsor: Marvao Medical
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: 9d828f9b5690ec713f60ddb7830fc144c05652f2792f0fb35e0c6d5d8841777b
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
